Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-04T20:18:30.061Z Has data issue: false hasContentIssue false

Pomegranate extract: a potential protector against aminoglycoside ototoxicity

Published online by Cambridge University Press:  22 January 2014

V Kahya
Affiliation:
Otorhinolaryngology Department, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey
B Ozucer*
Affiliation:
Otorhinolaryngology Department, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey
R Dogan
Affiliation:
Department of Otolaryngology, Bayrampasa State Hospital, Istanbul, Turkey
A Meric
Affiliation:
Otorhinolaryngology Department, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey
M Yuksel
Affiliation:
Medical Laboratory Department, Vocational School of Health Related Professions, Marmara University, Istanbul, Turkey
O Gedikli
Affiliation:
Otolaryngology Department, School of Health Related Professions, Kirklareli University, Turkey
O Ozturan
Affiliation:
Otorhinolaryngology Department, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey
*
Address for correspondence: Dr Berke Ozucer, Department of Otorhinolaryngology, Medical Faculty, Bezmialem Vakif University, Fatih, Istanbul, Turkey Fax: +90 2125332326 E-mail: [email protected]

Abstract

Objective:

To investigate the effectiveness of pomegranate extract as protection against aminoglycoside ototoxicity.

Design:

Prospective, randomised, controlled, experimental study.

Subjects:

Eighteen Wistar albino rats were randomly allocated to 5 days of either: saline injections; gentamicin injections; or pomegranate extract (100 µl/day via gavage) plus gentamicin injections. Distortion product otoacoustic emissions were tested before treatment and on day 3. After treatment, reactive oxygen species levels were measured in each rat's right cochlea and right kidney via chemiluminescence.

Results:

Baseline emission amplitudes were similar. Post-treatment emissions differed significantly in the two treatment groups (p < 0.001). Cochlear reactive oxygen species levels were significantly higher in the gentamicin group (mean ± standard deviation, 316.6 ± 36.5 relative light units per mg) than the gentamicin plus pomegranate extract group (240 ± 24.6 relative light units per mg) (p = 0.004); control group levels were 119.1 ± 10.3 relative light units per mg. Renal reactive oxygen species levels were similar for the control and gentamicin plus pomegranate extract groups (p = 0.59) but much higher in the gentamicin group (p = 0.004).

Conclusion:

Concurrent systemic pomegranate extract administration reduced reactive oxygen species level increases and otoacoustic emission changes, following aminoglycoside injection.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Schacht, J. Aminoglycoside ototoxicity: prevention in sight? Otolaryngol Head Neck Surg 1998;118:674–7Google Scholar
2Forge, A, Schacht, J. Aminoglycoside antibiotics. Audiol Neurootol 2000;5:322CrossRefGoogle ScholarPubMed
3Kopke, R, Allen, KA, Henderson, D, Hoffer, M, Frenz, D, Van de Water, T. A radical demise. Toxins and trauma share common pathways in hair cell death. Ann N Y Acad Sci 1999;884:171–91Google Scholar
4Sha, SH, Schacht, J. Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res 1999;128:112–18Google Scholar
5Lopez-Gonzalez, MA, Delgado, F, Lucas, M. Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats. Hear Res 1999;136:165–8CrossRefGoogle ScholarPubMed
6Lopez-Gonzalez, MA, Guerrero, JM, Rojas, F, Delgado, F. Ototoxicity caused by gentamicin is ameliorated by melatonin and other antioxidants. J Pineal Res 2000;28:7380Google Scholar
7Sinswat, P, Wu, WJ, Sha, SH, Schacht, J. Protection from ototoxicity of intraperitoneal gentamicin in guinea pig. Kidney Int 2000;58:2525–32Google Scholar
8Nordang, L, Anniko, M. Nitro-L-arginine methyl ester: a potential protector against gentamicin ototoxicity. Acta Otolaryngol 2005;125:1033–8CrossRefGoogle Scholar
9de Nigris, F, Williams-Ignarro, S, Sica, V, Lerman, LO, D'Armiento, FP, Byrns, RE et al. Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res 2007;73:414–23CrossRefGoogle Scholar
10Tugcu, V, Kemahli, E, Ozbek, E, Arinci, YV, Uhri, M, Erturkuner, P et al. Protective effect of a potent antioxidant, pomegranate extract, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 2008;22:2723–31CrossRefGoogle ScholarPubMed
11Aviram, M, Dornfeld, L. Pomegranate extract consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001;158:195–8CrossRefGoogle Scholar
12Lopez-Gonzalez, MA, Guerrero, JM, Torronteras, R, Osuna, C, Delgado, F. Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugs. J Pineal Res 2000;28:2633CrossRefGoogle ScholarPubMed
13Polat, Ş, Öztürk, Ö, Üneri, C, Yüksel, M, Haklar, G, Bozkurt, S et al. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin E treatment. Laryngoscope 2004;114:720–5CrossRefGoogle ScholarPubMed
14Haklar, G, Sayin-Özveri, E, Yüksel, M, Aktan, , Yalçın, AS. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001;165:219–24Google Scholar
15Nakashima, T, Teranishi, M, Hibi, T, Kobayashi, M, Umemura, M. Vestibular and cochlear toxicity of aminoglycosides – a review. Acta Otolaryngol 2000;120:904–11Google Scholar
16Halsey, K, Skjönsberg, A, Ulfendahl, M, Dolan, DF. Efferent-mediated adaptation of the DPOAE as a predictor of aminoglycoside toxicity. Hear Res 2005;201:99108CrossRefGoogle ScholarPubMed
17Priuska, E, Schacht, J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 1995;50:1749–52Google Scholar
18Sha, SH, Schacht, J. Formation of reactive oxygen species following bioactivation of gentamicin. Free Rad Biol Med 1999;26:341–7Google Scholar
19Sha, SH, Zajic, G, Epstein, CJ, Schacht, J. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol Neurootol 2001;6:117–23Google Scholar
20Hirose, K, Hockenbery, DM, Rubel, EW. Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear Res 1997;104:114CrossRefGoogle ScholarPubMed
21Clerici, WJ, DiMartino, DL, Prasad, MR. Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro. Hear Res 1995;84:3040Google Scholar
22Aviram, M, Dornfeld, L, Kaplan, M, Coleman, R, Gaitini, D, Nitecki, S et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 2002;28:4962Google Scholar
23Tsuda, T, Horio, F, Osawa, T. Cyanidin 3-O-beta-D-glucoside suppresses nitric oxide production during a zymosan treatment in rats. J Nutr Sci Vitaminol (Tokyo) 2002;48:305–10Google Scholar
24Maniu, A, Perde-Schrepler, M, Cosgarea, M. Protective effect of L-N-acetylcysteine against gentamycin ototoxicity in the organ cultures of the rat cochlea. Rom J Morphol Embryol 2011;52:159–64Google Scholar
25Liu, HY, Chi, FL, Gao, WY. Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea. Neuroreport 2008;19:117–20Google Scholar
26Walker, PD, Shah, SVL. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988;81:334–41CrossRefGoogle ScholarPubMed